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Abstract
Background: The primary objective of this study was to
measure influenza vaccination coverage rates in the general
population, including children, and in high-risk groups of five
European countries during the season 2007/2008. An addi-
tional aim was to analyze coverage trends over seven con-
secutive seasons and to gain an understanding of the primary
drivers and barriers to immunization.
Methods: Community-based telephone and mail surveys
have been conducted in the UK, Germany, Italy, France, and
Spain, yearly, since 2001/2002. Approximately 2,000 indi-
viduals per country and season were interviewed who were
considered to be representative of the adult population aged
14 years and older. Data on the vaccination status of chil-
dren were obtained by proxy interviews. The questionnaire
used was essentially the same for all seven seasons. Five
target groups were identified for the study: (1) persons aged
‡ 65 years; (2) elderly suffering from a chronic illness; (3)
patients suffering from a chronic illness; (4) persons working
in the health care sector; (5) children.
Results: In the season 2007/2008, vaccination coverage
rates in the general population remained stable in Germany.
Compared to the coverage rates of the previous season,
increases of 3.7%, 2.0%, and 1.8% were observed for the
UK, Spain, and France, respectively, while a decrease of
–1.5% was observed for Italy. Across all five countries,
vaccination rates in the predefined target groups decreased
to some extent (elderly) or increased slightly (chronically ill
and health care workers). Vaccination rates among children
varied strongly between countries and ranged from 6.1%
in UK to 19.3% in Germany. The most powerful motivation
for getting vaccinated in all countries was advice from a
family doctor (58.6%) and the perception of influenza as a
serious illness (51.9%). The major reasons why individuals
did not become vaccinated were (1) the feeling of not being
likely to catch influenza (39.5%) and (2) never having
considered the option of being vaccinated (35.8%).
Conclusions: The change in general influenza vaccination
coverage in the 2007/2008 season compared to the previ-
ous season was small, but decreases were seen in some
target groups. The underlying motivations for and against
vaccination did not substantially change. An effort to
activate those driving forces that would encourage vacci-
nation as well as dealing with barriers that tend to prevent
it may help enhance coverage rates in Europe in the future.
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Introduction
The main objective of infectious disease surveillance
according to the European Centre for Disease Prevention
and Control (ECDC) is to reduce the incidence and
prevalence of communicable diseases [1]. The significance
of routine monitoring is especially pertinent in the case of
influenza vaccination. Influenza epidemics occur nearly
every winter and account for considerable mortality and
morbidity with three to five million cases of severe illness
and between 250,000 and 500,000 deaths every year
worldwide [2]. The highest rates of serious illness or death
occur among the elderly over 65 years of age and among
chronically ill patients [2, 3].
The most appropriate action for the prevention and
reduction of the burden of influenza epidemics is vacci-
nation [2]. Influenza vaccine is a trivalent vaccine and
needs to be updated annually. The effectiveness of inac-
tivated influenza virus vaccine has been confirmed in
several studies among all age groups [4–6]. Furthermore,
vaccination has been shown to be both cost-efficient and
cost-saving [7–9]. Children experience high attack rates
that may reach 40% of the general pediatric population
during annual influenza epidemics [10]. Consequently, the
vaccination of children not only implies protection for
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each child but also avoids absenteeism of parents caring
for their sick children and provides additional benefits due
to the effects of herd immunity [11, 12].
Recommendations at the European level are that
persons over 65 years of age and individuals with under-
lying chronic illnesses should receive influenza vaccina-
tion. Since continuing efforts are required to tie in
national regulations of the Member States with the
improvements and developments induced by the Program
of Community Action in the field of public health (2003–
2008), the European Parliament has established a second
program of Community Action on Health (2008–2013)
[13, 14]. National regulations vary in some Member States
from the recommendations of these programs. Current
government vaccination policies in the UK, Germany,
Italy, France and Spain are based on age, with vaccination
generally being recommended for individuals 65 years of
age and older (except in Germany, where the age cut-off
is set at 60 years), and the presence of chronic medical
conditions, such as chronic pulmonary diseases (asthma
included), cardiovascular diseases (except hypertension),
renal diseases, hepatic diseases (except Italy and France),
hematological or metabolic disorders (such as diabetes
mellitus), immunological disorders, including HIV/AIDS
(in France, the doctor who is in charge of the HIV patient
has to indicate the advice for vaccination), and pregnancy
(in Italy and Spain) [15–19]. The vaccination of health
care workers is also recommended. Hence, the meaning of
a high influenza coverage rate in the general population
and especially in the at-risk groups is underlined and
supported by several stakeholders.
Current pediatric guidelines do not recommend vac-
cination in healthy children, whereas children aged
‡ 6 months with diabetes, cardiac or renal diseases, an
immune-compromised or HIV-positive status (except
Italy). or receiving chronic aspirin therapy (except Ger-
many and UK) should receive the vaccine [20].
This cross-sectional study focuses on current vacci-
nation coverage rates and related trends in five European
countries during seven consecutive influenza seasons. The
emphasis is not only on vaccination status in high-risk
groups and children but also on an inter-country com-
parison of drivers for and barriers against vaccination, and
vaccination intentions for the following season 2008/2009.
Methods
Study Design
A population-based cross-sectional survey was carried out in the
2007/2008 influenza season in the UK, Germany, Italy, France,
and Spain. During seven consecutive influenza seasons, from
2001/2002 to 2007/2008, representative household surveys were
conducted using the same methodology. The fieldwork meth-
odology has been described earlier [21]. In brief, telephone
interviews were conducted by TNS healthcare using a computer-
assisted telephone interviewing system (CATI) in all countries
except France. French data were collected via a postal ques-
tionnaire compiled and administered by GEIG (Groupe d’Etude
et d’Information sur la Grippe). Adults with children replied for
each child (up to five children per interviewee). To obtain a
representative sample of the national non-institutionalized adult
population, interviews were carried out according to quotas, and
a weighting was applied with respect to gender, age, profession,
geographic region, and town size. Quotas and weighting factors
were based on data from official national sources [22].
Subjects
The survey populations were representative of the adult pop-
ulation aged 14 years or older in Germany, Italy and Spain,
15 years or older in France, and 16 years or older in the UK. In
Spain, individuals over 75 years of age were not included in the
survey. The surveys were carried out in December and January.
As in the previous seasons, approximately 2,000 interviews
were conducted per country (UK: 2007, Germany: 2002, Italy:
2000, Spain: 2000). In France, 4,576 persons responded to the
questionnaire. In order to adjust the sample size with that of
the other countries, the French data were weighted according
to standard criteria to represent 2,000 individuals instead of
4,576.
At the beginning of each telephone call, the agreement and
explicit verbal consent of the interviewees was obtained. There
was no study intervention, and the anonymity of the participants
was guaranteed. According to the Esomar World Research
Codes and Guidelines, this type of study is considered market
research and does not require the approval of an ethics com-
mittee, as this survey is a study of people who are deemed
healthy and not, therefore, in the medical system [23].
Cross-Sectional Survey
The survey questions have been published earlier [22]. Across all
countries, the questionnaire remained basically the same during
the complete study period. Data from Spain have been available
since 2002/2003.
In 2007/2008, the questionnaire covered vaccination uptake
as well as reasons for and against vaccination. Information on
chronic illnesses was collected from 2003/2004 onwards. In order
to identify chronically ill persons, examples were provided to the
respondents (heart or lung disease, diabetes or others), and the
type of the disease has been reported beginning in 2007/2008.
The vaccination status of children was recorded in all countries
except France beginning in 2005/2006. The upper age limits of
the children differed between countries (13 years in Germany,
Italy and Spain; 14 years in France; 15 years in the UK). In
addition to the vaccination status, data collection covered the age
of the children and the number of children per family. Questions
regarding avian influenza were added in the 2005/2006 season,
and the current questionnaire contains questions on the concerns
of respondents for experiencing side effects from the vaccine and
if traveling to known high-risk regions (in terms of influenza)
would encourage them to get vaccinated.
Statistical Analysis
Based on the above-described recommendations [15–19], we
defined four at-risk groups for the 2003/2004 to 2007/2008 influ-
enza seasons as follows: (1) individuals aged 65 years or older;
(2) elderly suffering from a chronic illness; (3) other individuals
suffering from a chronic illness; (4) individuals working in the
medical field (health care workers). Persons belonging to none of
the four above-defined target groups were classified as members
of the non-target group. Children were treated separately.
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The annual datasets were pooled (for analysis across all five
countries), and sample weights were applied to correct for small
deviations from the age and gender quotas required. SPSS
version 14 for Windows (SPSS, Chicago, IL) was used for the
statistical evaluation. To avoid double counting – for example,
those over 65 years who also have a chronic illness or those
health care professionals who suffer from a chronic illness – we
analyzed the vaccination coverage rates in at-risk groups vs the
non-target group (including individuals less than 65 years of age
without a chronic illness and not working in the health care
sector).
Bivariate associations of categorical variables were assessed
with the v2 test, and the v2 test for trend was used for evaluating
time trends of these variables. For all statistical tests, two-sided
p £ 0.05 was used as the level of statistical significance. Ninety-
five percent confidence intervals (CI) are reported as appropri-
ate. Due to the descriptive nature of this data, no corrections for
multiple testing were made.
Covariates identified as potential predictors of influenza
vaccination in univariate analysis were considered as candidates
for multivariable analysis. Logistic regression was used to iden-
tify the independent explanatory value of correlates of the out-
come of interest, i.e. vaccination coverage. The following
variables were regarded as potential predictors of vaccination
coverage: gender, age, chronic illness, working in the medical
field, educational level, and household income. All covariates
were included in the initial models for the 2007/2008 data from
each country. Non-significant predictors (p > 0.05) were subse-
quently removed on a stepwise basis. However, covariates that
were significant for any country were retained in all models in
order to facilitate comparison.
The data for the children are presented separately due to the
different data acquisition process on the basis of proxy respon-
dents.
Results
Vaccination and Intention Rates in the General
Population
Characteristics of the survey participants are summarized
in table 1. The response rate, including valid interviews,
refusals, interviews beyond the quotas, and appointments,
across all countries was 58% (UK 33%, Germany 54%,
Italy 72%, Spain 55%, France 76%). Among all of those
approached using the telephone, 15% completed the
telephone interview (UK 4%, Germany 7%, Italy 22%,
Spain 28%).
Figure 1 shows vaccination coverage rates for the
current season 2007/2008 and trends over the last seven
seasons. In the 2007/2008 season, coverage rates in the
general population ranged from 22.9% in Italy to 28.7%
in the UK. Compared to the previous season of 2006/2007,
a statistically significant increase was only seen in the UK
(p = 0.008). However, a long-term positive development
of the coverage rates was confirmed for all countries
(Figure 1). A transitory peak in the 2005/2006 season can
be attributed to fear of the avian influenza, which received
high media attention at the time.
By grouping the sample in eight different age classes,
we confirmed an ascending curve shape with advancing
age. In the UK and Spain, the highest coverage was found
in the 70- to 74-year-old population (87.0%, 95%CI
81.0–93.0%; 72.8%, 65.8–79.8%, respectively). In the other
countries, the coverage was highest in the group aged 75
years and older, reaching 70.7% (95%CI 63.7–77.7%) in
Germany, 72.2% (95%CI 66.2–78.2%) in France, and
Table 1
Overview of adult sample in season 2007/2008.
Variables UK Germany Italy France Spain All
Sample size 2,007 2,002 2,000 2,000 2,000 10,009
Mean age (years) 45.4 48.1 45.5 46.6 42.2 45.6
95% CI 44.6–46.2 47.3–48.9 44.7–46.2 45.8–47.5 41.5–43.0 45.2–45.9
Male 48.5% 48.0% 48.7% 48.3% 49.6% 48.6%
95% CI 46.4–50.7% 45.8–50.2% 46.4–50.8% 46.0–50.5% 47.4–51.8% 50.4–52.4%
Age ‡ 65 years 19.6% 24.7% 17.4% 20.1% 12.3% 18.8%
95% CI 18.6–21.6% 22.7–26.7% 16.4–19.4% 18.1–21.1% 11.3–14.3% 17.8–19.3%
Work in the medical field 8.5% 8.5% 3.8% 6.3% 6.7% 6.8%
95% CI 7.3–9.8% 7.3–9.7% 2.9–4.6% 5.2–7.4% 5.6–7.8% 6.3–7.3%
Chronic illness 15.3% 24.9% 10.6% 16.3% 14.4% 16.3%
95% CI 13.7–16.9% 23.0–26.8% 9.3–12.0% 15.0–18.4% 12.9–16.0% 15.–17.1%
Respondents with at least one child 22.4% 17.5% 24.4% NA 21.9%
Children (n) 823 546 750 646 2765
Households by number of children
0 77.6% 82.5% 75.6% NA 78.1% 82.7%
1 8.6% 9.7% 13.5% NA 12.6% 8.9%
2 9.9% 6.1% 9.3% NA 8.3% 6.7%
3 3.1% 1.3% 1.4% NA 0.8% 1.3%
4 0.6% 0.3% 0.2% NA 0.1% 0.2%
5+ 0.2% 0.1% 0.1% NA NA 0.1%
NA: Data not available
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72.4% (95%CI 64.4–81.4%) in Italy. The lowest coverage
was seen in the population aged below 39 years in all five
countries.
Vaccination Rates in At-Risk Groups
Age
Trends in vaccination coverage rates in the elderly (over
65 years of age) without chronic illnesses are given in
figure 2a. In the current season of 2007/2008, enhanced
vaccination uptake compared to the year before was found
in the UK and France, even though this increase could not
be statistically confirmed (p = 0.226 and p = 0.716, respec-
tively).
Chronic Illness
The distribution of chronic illnesses (regardless of age) is
presented in table 2 for all of the countries except France,
for which these data were not available. A high propor-
tion of these patients declared themselves as suffering
from cardiovascular disease, and this subgroup seemed to
be more likely to get vaccinated (average of countries:
odds ratio [OR] 1.8, 95%CI 1.4–2.3, p £ 0.0001). Dia-
betes patients had an OR of 2.2 (95%CI 1.7–2.9,
p £ 0.0001) compared to non-diabetes patients.
Figure 2c presents the vaccine coverage among chronic
illness patients below the age of 65 years. The highest
coverage was found in UK (56.7% 95%CI 49.7%–63.7%),
despite a non-significant decrease compared to 2006/2007
(p = 0.523). France was the only country with a statisti-
cally significant positive trend across time (p = 0.024). The
reverse was true for Germany where a negative trend was
identified (p = 0.025) and a minimum of 26.5% (95%CI
21.5%, 32.5%) was reached in season 2007/2008.
Elderly with Chronic Illness
Our data show a rising proportion of chronic illnesses with
advancing age. Across all countries we found that 8.8%
(95%CI 8.1–9.5%) of the individuals under the age of
50 suffered from chronic illnesses, whereas in those aged
65 years or older, the proportion was 33.3% (95%CI
31.2–35.5%). The vaccine uptake was particularly high in the
combined at-risk group (Figure 2b). Statistically significant
results across time were found in Germany (p £ 0.0001)
(Figure 2b).
Health Care Workers
During the interviews, respondents working in the health
care sector were asked to disclose their profession
(Table 2). Within this target group, the highest influenza
vaccine uptake, 34.2%, was found among nursing profes-
sionals (across all countries, 95%CI 12.2–56.2%).
Employees from the medical or the paramedical field had
average rates of 26.5% or 19.4%, respectively.
The vaccination uptake by health care workers is
shown in figure 2d. In general, the uptake among these at-
risk persons was low, and there is no evidence of a positive
development over time. The best vaccinated group was
found in Spain (25.4%, 95%CI 18.4–23.4%). Vaccination
coverage was poor in Italy – 10.9% (95%CI 2.9–18.9%) –
where a negative time trend was noted (p-value across
seasons: 0.034).
Non-target Group
In 2007/2008, the coverage of the non-target group ranged
from 10.6% (95%CI 8.6%–11.6%) in the UK to 14.5%
(95%CI 11.5%–16.5%) in Germany (Figure 2e). Compared
to the previous season, only marginal changes were noted.
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Figure 1. Vaccination coverage
rates (VCR) in the general
population during seven
influenza seasons. Error bars:
95% confidence interval;
p-value: trend over time.
P.R. Blank et al. Disparities in Influenza Vaccination Coverage Rates
Infection 37 Æ 2009 Æ No. 5  URBAN & VOGEL 393
Odds Ratios of At-Risk Groups for Getting
Vaccinated
In the final multivariate logistic regression models, the fol-
lowing covariates were taken into account as potential
predictors of getting vaccinated: target group membership
(age, chronic illness, working as health care worker), higher
educational level, and higher household income. Gender
was not found to be a significant predictor and hence was
not taken into account. For the UK, no information on
education was available, and in data on income and edu-
cation level were not available for France. The resulting
adjusted ORs of vaccination are shown in table 3.
As shown in table 3, being elderly and suffering from
a chronic medical condition were powerful predictors for
getting vaccinated in all five countries. As expected, per-
sons with both characteristics combined showed even
higher ORs. On the other hand, being employed in the
health care sector was a statistically significant explana-
tory variable in the UK, France, and Spain only. German
and Italian medical employees did not seem to be more
likely to get vaccinated. These two countries also had the
lowest actual coverage rates in 2007/2008 (Figure 2d).
A higher income (‡ 2,500e per month) did not seem to
be a factor which positively influenced the decision to get
Error bars: 95% confidence intervals
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Figure 2. Vaccination coverage rates (VCR) in at-risk populations during five influenza seasons. a VCR rates in the elderly, b VCR in the elderly
chronic ill patients, c VCR in chronically ill patients, d VCR of health care workers, e VCR of non-target group members. Error bars: 95%
confidence interval; p-value: trend over time.
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vaccinated. In Germany and Spain, the ORs of 0.7 and 0.6,
respectively, were statistically confirmed (p-values = 0.021
and 0.022, respectively). Hence, individuals with a higher
income appear to get less vaccinated in these countries.
Individuals with a higher educational level (superior
studies, university degree, high school, technical college)
were also less prone to get vaccinated than those with
a lower education. This was especially true for Italy
(OR 0.6, p = 0.004), whereas the reverse was true for
Spanish graduates, which were more likely to receive the
vaccine (OR 1.4, p = 0.082).
Vaccination Coverage Rates in Children
In our study, the vaccination coverage rates among the
interviewee’s children were assessed during three seasons.
The results are presented in figure 3. French data were
Table 2
At-risk group population according to medical condition/profession (2007/2008).
Persons with chronic disease UK Germany Italy Spain All
n 307 498 212 289 1,306
Type of disease (%)
Respiratory 49.7 31 24.1 37.7 35.6
Cardiovascular 23.6 37.1 33 16 27.4
Diabetes 32.9 22.5 19.2 17.7 23.1
Transplantations 1 0.1 0.4 0.4 0.5
Long-term cancer survivals 3.7 4.7 2.3 2.8 3.4
Others 19.1 22.7 23.5 28.4 23.4
Health care field (2007/08) UK Germany Italy France Spain All
n 171 170 75 58 133 607
Health care workers (%)
Nursing 39.3 36.9 16.2 37.9 28.6 31.8
Paramedicala 13.3 16.1 28.4 41.4 30.8 26.0
Medical 22.0 22.0 28.4 5.2 12.8 18.1
Non-clinical/medicalb 4.6 13.7 17.6 NA 18.0 13.5
Others 9.2 NA 6.8 6.9 NA 7.6
a Pharmacist, physiotherapist, masseuse; bAdministrative, assistant, receptionist, pharmaceutical company
NA: Data not available
Table 3
Adjusted odds ratios of vaccination coverage in target groups in the 2007/2008 season (adjustment for age ‡ 65 years, chronic illness,
working in the medical field, income and education).
Variable UK Germany Italy France Spain
na 2,004a 1,991a 1,257 4,415a 1,994a
Ageb 19.1 5.3 7.1 14.3 7.5
95% CI 13.8–26.4 4.0–7.2 5.0–10.2 10.5–19.6 4.6–12.2
p-value <0.001 <0.001 <0.001 <0.001 <0.001
Chronic illnessb 10.7 2.1 4.5 4.9 4.0
95% CI 7.5–15.1 1.5–2.9 2.8–7.3 3.5–6.9 2.7–6.1
p-value <0.001 <0.001 <0.001 <0.001 <0.001
Chronic illness and ageb 85.9 17.9 12.8 31.7 15.7
95% CI 43.7–169.0 12.5–25.7 7.1–22.8 19.7–51.0 7.9–31.4
p-value <0.001 <0.001 <0.001 <0.001 <0.001
Work in medical fieldb 2.7 1.2 0.9 2.3 2.0
95% CI 1.8–4.1 0.8–2.0 0.3–2.6 1.4–3.8 1.1–3.6
p-value <0.001 0.389 0.835 0.001 0.032
Income per month (< 2499ec/> 2500e) 0.9 0.7 0.7 NA 0.6
95% CI 0.7–1.1 0.6–1.0 0.3–1.6 – 0.4–0.9
p-value 0.243 0.021 0.379 – 0.022
Education (low or no educationc/higher education) NA 0.9 0.6 NA 1.4
95% CI – 0.6–1.4 0.5–0.9 – 1.0–2.1
p-value – 0.705 0.004 – 0.082
a n < total sample size for this season due to missing covariate values; b reference category is non-target group (persons who do not belong to
any target group); c Reference category
NA: Not available
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not available. Table 1 shows the total size of the pediatric
sample and household according to number of children.
In 2007/2008, parents in all countries with the excep-
tion of the UK, vaccinated their children more frequently
than in the previous season (2006/2007). In Germany and
Italy, the coverage differed significantly from that ob-
served in the previous season (p = 0.016 and p = 0.032,
respectively) (Figure 3a). This was particularly evident for
Italian and British children 0–2 years of age (Italian:
24.5%, 95%CI 16.5–33.5%; British: 13.4%, 95%CI
7.4–19.4%). In Germany, children aged 7–10 years old had
the highest vaccination rate (23.6%, 95%CI 16.6–29.6%),
and in Spain, children aged 11–15 years showed the highest
influenza vaccination level (15.9%, 95%CI 9.9–21.9%).
Figure 3b shows the vaccination status of children ac-
cording to age group for the 2007/2008 season.
Parents who belonged to one or more at-risk groups
(older age, chronic illness, health care worker) were not
more likely to vaccinate their children. This trend was
especially evident in Germany there was a strong negative
association between target group membership of the adult
respondent and vaccination rate in the children from these
households (OR 0.5, 95%CI 0.3–0.9, p = 0.019 compared to
children in the households of non-target group respondents).
Reasons for and Against Vaccination
The principal barriers against and the strongest driving
forces for vaccination have been extensively reported in
earlier publications [22, 24–26]. In 2007/2008, the ranking
of the statements given by both vaccinated and non-vac-
cinated individuals did not greatly differ from that of
previous seasons (Table 4).
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Figure 3. Vaccination coverage
among children (2005/2006–
2007/2008). a Vaccination
coverage rates (VCR) in children
by country (0–15 years), b VCR
among children by age groups
(season 2007/2008). Error bars:
95% confidence interval;
p-value: change over time.
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In addition to the advice from a family doctor (58.6%
across all country) and the perception of influenza being a
serious illness (51.9%), environmental and lifestyle factors
may influence the decision for vaccine uptake. For
example, traveling to the tropics presents a permanent,
modest risk of getting infected [27]. Hence, traveling to
high-risk regions in terms of influenza was mentioned by
8.4% of the UK citizens as a reason for vaccination,
whereas this did not play a role in the Spanish population
(1.2%). More than 17% of the British population was
driven by the media attention on avian influenza and
influenza pandemics to get vaccinated. This was a 2.5-fold
increase in the vaccination rate over the previous season
(p £ 0.0001). Concerns regarding possible side effects
from the vaccine seemed to be an obstacle for vaccination,
especially among Germans (34.5%), whereas only 4.4% of
the Spanish population stated this as a reason for not
getting vaccinated. To some extent, persons suffering
from chronic illnesses or elderly individuals stated other
reasons which were mostly related to the respondent’s
condition.
In the influenza season 2007/2008, the most common
reason for not being vaccinated among those persons who
had never been vaccinated was the feeling that they were
not likely to catch the influenza (across Europe: 38.8%).
For patients with chronic illnesses, another strong argu-
ment was never having ever considered being vaccinated
or the absence of a recommendation from a health pro-
fessional (across Europe: 30.5% and 29.9%, respectively).
Elderly persons expressed concerns about possible side
effects of the vaccine (across Europe: 25.1%) and that they
forgot to go for the vaccination (across Europe: 23.4%).
Drivers of vaccination were very similar as those
found in the previous seasons [26]. Based on a new
questionnaire item, a high proportion of respondents
would get vaccinated should they travel to regions with a
high risk of influenza (range: 15.0% in Italy to 73.8% in
Germany).
Discussion and Conclusion
There is no global system of monitoring vaccination cov-
erage in Europe. The UK has a system to observe the
coverage of all at-risk groups, while Spain has no such
system whatsoever. The Italian, French, and German
surveillance systems are strictly limited to a limited
number of at-risk groups. The official German, British,
and Italian influenza vaccination coverage data are based
on surveys, administrative data are used for this purpose
in France and Spain [28]. Therefore, cross-country
assessments based on a uniform methodological approach,
as reported here, are of particular importance. Telephone
surveys are known to be a reliable method for monitoring
influenza vaccination among the general population. They
also have the advantages of being fast (in terms of data
collection) and cost efficient and provide data not only on
vaccination status but also on the attitude of the popula-
tion towards vaccination. Hence, the ability to maintain
quality control over the entire data collection process
makes telephone surveys a valid method to monitor the
vaccination status of populations [29].
Table 4
Reasons for and against vaccination in the general population (season 2007/2008).
Vaccinated population UK Germany Italy France Spain All
n 576 562 458 521 475 2,592
Motivations for getting vaccinateda (%)
My family doctor/nurse advised me to do it 81.9 76.4 49.1 31.8 53.7 1 (58.6%)
Because the flu is a serious illness and
I did not want to get it
83.5 88.7 17.7 35.1 34.3 2 (51.9%)
Because of my age 60.0 47.7 15.2 34.3 36.6 3 (38.8%)
So I do not pass the flu bug to my family/friends 61.9 73.9 14.6 18.8 24.2 4 (38.7%)
Because the social security system pays for it 51.5 42.4 4.8 44.3 17.7 5 (32.1%)
Because I am not in good health 37.5 31.9 19.1 13.9 27.5 6 (26.0%)
To prevent me from interrupting my professional activity 36.7 25.4 13.3 12.5 18.6 7 (21.3%)
Non-vaccinated population UK Germany Italy France Spain All
n 1,152 910 1,375 1,231 1,276 5,944
Reasons for not getting vaccinateda (%)
I do not think I am very likely to catch the flu 45.5 46.7 23.8 15.4 66.1 1 (39.5%)
I have never considered it before 51.3 32.3 32.4 20.4 42.4 2 (35.8%)
My family doctor has never recommended it to me 59.6 32.0 13.9 19.0 38.9 3 (32.7%)
I am too young to be vaccinated 44.6 8.7 18.5 35.0 13.3 4 (24.0%)
It is not a serious enough illness 37.4 37.7 13.0 9.3 8.9 5 (21.3%)
a Reasons for getting or not getting vaccinated are given as a percentage and are ranked (column ‘‘All’’) in order of perceived importance by
respondents
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There are some limitations to our study that need to
be addressed. We were not able to confirm self-reported
vaccination uptake or chronic condition status. Never-
theless, previous publications have shown that self-
reported data have an adequate degree of reliability,
supporting out study approach [22, 30, 31]. Our method-
ological approach was designed to gather a representative
population sample despite low response rates. The grow-
ing amount of answering machines, voicemail systems,
caller IDs, and mobile phones certainly creates a chal-
lenge for those carrying out telephone surveys [32]. Indi-
viduals with only a mobile telephone were not integrated
in our survey, for the primary reason as they are generally
not included in telephone surveys. In addition, such indi-
viduals are usually more difficult to reach, and the costs of
such interviews are much higher. Therefore, selection bias
due to non-response cannot totally be excluded.
Across the countries, the size of the at-risk groups
differed to some extent. This can be attributed to the fact
that the sample in Spain included people up to 75 years of
age only, whereas the surveys in all other countries in-
cluded older individuals. The differences in the proportion
of chronically ill patients may stem from local variations
in the understanding of the term chronic illness. Although
the question asked was the same in all five countries, the
threshold of defining oneself as being chronically ill may
be subject to cultural influences. The high proportion of
chronically ill persons in Germany has been reported in
earlier publications, but no clear explanation has ever
been provided [26, 33]. It is also possible that the age cut-
off of 75 years in the Spanish survey may have impacted
on the prevalence of certain chronic illnesses in the
Spanish survey population.
In our survey conducted in UK, Germany, France,
Italy and Spain, we found that influenza coverage rates in
the general population were about the same as that in the
year before. Over the entire study period of 7 years, a
positive, statistically significant trend was visible in each
of the five countries. An improved and efficient reminder
system in Europe may help to enhance coverage rates.
People need to be reminded before or during the immu-
nization season, i.e., between September and November,
that they should make the effort of being vaccinated. A
study conducted in the USA by Jacobson et al. identified
this as a common reason why adults do not receive
immunizations [34]. These authors demonstrated that re-
minder and recall systems were effective in improving
influenza immunization rates in children and adults [35].
In the target groups for which vaccination is recom-
mended, the influenza coverage level did not generally
improve since the previous season 2006/2007. In the el-
derly group over 65 years of age, not all countries appear
to be on the way to meeting the World Health Organi-
zation’s (WHO) target of 75% vaccination coverage in
2010/2011 [14], while some countries are now quite close
(UK 70.2%). However, similar rates in the other target
groups are nowhere near approaching this target. Specif-
ically, the coverage of chronically ill persons continues to
be much lower than that which has been achieved among
the elderly, despite a positive trend in some countries
(Germany and France). Equally important, health care
workers do not appear to have a strong inclination to get
vaccinated. The coverage level in this group was low and
has even seemed to spiral downwards over the past few
years in Italy. This fact has been documented by several
European studies with comparable results [36, 37].
In the UK, the Health Protection Agency (HPA) on
behalf of Department of Health has carried out annual
vaccine uptake surveys that gather data on registered
patients in all general practices by a web-based reporting
system [38]. During the season 2007/2008, HPA revealed
similar coverage rates as our survey among the elderly
(73.5% vs 70.2%, respectively). The percentage of vacci-
nated chronically ill patients (below 65 years) was 45.3%
in the HPA analysis, which is lower than the 56.0% ob-
served by our survey [39]. It should be noted that we
avoided double counting by analyzing all risk-groups
separately. As this was not the case in the HPA study for
the aged group, a higher vaccination coverage would be
expected. On the other hand, the methodological ap-
proach is not exactly the same in both surveys. While the
HPA sample was collected from the medical records of
general practitioners’ (GP) patients, our survey covered
the entire population that could be reach by landline
telephone connections. Hence, the populations partici-
pating in these studies may vary in terms of health status
as well as in other respects. These differences suggest that
the comparability between the two surveys is limited [40].
The data on the vaccination status of children showed
a low coverage, ranging from 6.1% (UK) to 19.3%
(Germany) in 2007/2008, with positive trends in Germany.
There is no national policy in any of the five countries for
vaccinating healthy children. In comparison with the el-
derly target group, the influenza-related mortality rates
are low among the pediatric population (0.2–0.8 per
100,000), even though the hospitalization rate is consid-
erable [41]. Nevertheless, the prevention of influenza in
children may substantially reduce the risk of transmitting
the virus to family members and to the community [12,
42]. Hence, school-based influenza vaccination programs
could help to achieve a reduction in absenteeism and
extend the protection to unvaccinated individuals [43].
According to the ECDC, the lack of sufficient vaccination
coverage data in children makes the development of
specific guidelines complex [44]. Consequently, there are
no precise ECDC recommendations in place. Neverthe-
less, there is no evidence against the immunization of
children against influenza [45].
Motivations for vaccinations and barriers against it
were analyzed for both the general and at-risk popula-
tions. Health care workers were identified as playing an
important role in reminding and recommending influenza
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vaccination to both the general population and the target
populations. Our results further imply that there is a lack
of broad and effective communication campaigns aimed at
educating the public on influenza and influenza vaccines.
Johnson et al. recently reported similar findings on
obstacles to adult immunization, based on interviews with
health care providers [34]. Additional explanations re-
ported by these authors included concerns about side ef-
fects, vaccine shortage, infrequent patient visits, and the
fear of needles, as well the lack of knowledge on this topic
among health care professionals [34]. A further survey
carried out among GPs and hospital health care workers
found that doctors working in hospitals had restricted
access to guidelines and other information on vaccination
of the elderly. Hence, they were less likely to endorse the
vaccination of the elderly than GPs [46]. Such a lack of
awareness among groups of medical employees may have
a substantial negative impact on vaccination rates, given
the key importance of vaccination recommendations from
medical professionals.
Higher educational level is usually expected to posi-
tively influence vaccination uptake. The underlying
assumption is that educated people understand health
promotion messages better and that this leads to more
health protective behavioral patterns [47]. However, our
survey found a negative influence of educational level that
we cannot currently explain. In all countries, the national
governments fund, partially or fully, the cost of the vac-
cine and of vaccine administration in the at-risk groups.
For the elderly aged 65 years and above, vaccination is
free for all recipients [48]. In particular, the French
respondents regarded the funding of the vaccine as ex-
tremely motivating for getting immunized, not only in the
high-risk groups but also in individuals not at risk. State
funding may partially explain why higher income, as
higher educational level, did not have a positive impact on
vaccination coverage.
In light of our results, different approaches should be
combined to increase influenza vaccination coverage lev-
els in Europe. Approaches may include well-timed infor-
mation campaigns on seasonal influenza immunization,
with particular attention paid to targeting at-risk groups
and health care workers, improvement of vaccine acces-
sibility (both financially and logistically), the education of
health care professionals with respect to improving their
ability to identify at-risk patients and increasing the fre-
quency at which they advise patients to get vaccinated,
and the involvement of health care professionals in vac-
cination campaigns. Strong efforts have to be undertaken
at the national and international levels to realize the
challenging vaccination targets of the WHO in 2010/2011.
Increasing vaccination coverage is the primary means to
diminish the mortality and overall disease burden of
influenza. This research project provides some insights in
how the goal of containing the massive burden of disease
may better be achieved in the future.
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